PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-25.60%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-60.64%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
1.26%
Positive EBIT growth while MAXN is negative. John Neff might see a substantial edge in operational management.
-2402.01%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-126.30%
Negative net income growth while MAXN stands at 0.91%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-121.25%
Negative EPS growth while MAXN is at 0.93%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-127.00%
Negative diluted EPS growth while MAXN is at 0.93%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
10.75%
Share change of 10.75% while MAXN is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
13.64%
Diluted share change of 13.64% while MAXN is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
-7700.65%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-934.80%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-27.10%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-20.32%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
12.30%
Positive 3Y CAGR while MAXN is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
-635.26%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-23.78%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-16.38%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-106.42%
Negative 10Y net income/share CAGR while MAXN is at 55.64%. Joel Greenblatt sees a major red flag in long-term profit erosion.
88.32%
5Y net income/share CAGR above 1.5x MAXN's 55.64%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
99.12%
3Y net income/share CAGR above 1.5x MAXN's 55.64%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
-99.63%
Both are negative. Martin Whitman suspects the segment is in decline or saddled with persistent unprofitability or write-downs.
-99.51%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-99.06%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
67.60%
Our AR growth while MAXN is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
139.77%
Inventory growth well above MAXN's 6.79%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-8.03%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-15.74%
We have a declining book value while MAXN shows 1.77%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-0.27%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-14.37%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-6.94%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.